Publications

Export 3690 results:
Sort by: [ Author  (Asc)] Title Type Year
A B C D E [F] G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
F
Fouda, U. M., H. S. Elshaer, K. A. Elsetohy, and M. A. Youssef, "Misoprostol versus uterine straightening by bladder distension for pain relief in postmenopausal patients undergoing diagnostic office hysteroscopy: a randomised controlled non-inferiority trial.", European journal of obstetrics, gynecology, and reproductive biology, vol. 203, pp. 326-30, 2016 Aug. Abstract

OBJECTIVE: To compare the effectiveness of misoprostol with uterine straightening by bladder distension in minimising the pain experienced by postmenopausal patients during diagnostic office hysteroscopy.

STUDY DESIGN: Seventy-six postmenopausal patients were randomly allocated in a 1:1 ratio to the misoprostol group or to the bladder distension group. Patients in the misoprostol group were instructed to insert two misoprostol tablets (400μg) in the vagina 12h before office hysteroscopy. Patients in the bladder distension group were instructed to drink one litre of water and to avoid urination during a period of 2h before office hysteroscopy. The severity of pain experienced by the patients during and at 30min after the procedure was measured using a 100-mm visual analogue scale (VAS). The ease of passing the hysteroscope through the cervical canal was assessed by the hysteroscopists using a 100-mm VAS.

RESULTS: The passage of the hysteroscope through the cervical canal was easier in the misoprostol group [60.37±15.78 vs. 50.05±19.88, p=0.015]. The mean VAS pain score during the procedure was significantly lower in the misoprostol group [39.47±13.96 vs. 50.18±15.44, p=0.002]. The mean VAS pain score 30min post-procedure was comparable between both groups [11.82±3.71 vs. 12.61±4.06, p=0.379].

CONCLUSION: Vaginal misoprostol is more effective than uterine straightening by bladder distension in relieving the pain experienced by postmenopausal patients during office hysteroscopy.

TRIAL REGISTRATION: Clinicaltrials.gov [NCT02328495]. https://clinicaltrials.gov/ct2/show/NCT02328495.

Fouda, U. M., and A. M. Sayed, "Extended high dose letrozole regimen versus short low dose letrozole regimen as an adjuvant to gonadotropin releasing hormone antagonist protocol in poor responders undergoing IVF-ET.", Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, vol. 27, issue 12, pp. 1018-22, 2011 Dec. Abstract

OBJECTIVE: To compare the efficacy and cost-effectiveness of extended high dose letrozole regimen/HPuFSH-gonadotropin releasing hormone antagonist (GnRHant) protocol with short low dose letrozole regimen/HPuFSH-GnRHant protocol in poor responders undergoing IVF-ET.

METHODS: In this randomized controlled trial, 136 women who responded poorly to GnRH agonist long protocol in their first IVF cycle were randomized into two equal groups using computer generated list and were treated in the second IVF cycle by either extended letrozole regimen (5 mg/day during the first 5 days of cycle and 2.5 mg/day during the subsequent 3 days) combined with HPuFSH-GnRHant protocol or short letrozole regimen (2.5 mg/day from cycle day 3-7) combined with HPuFSH-GnRHant protocol.

RESULTS: There were no significant differences between both groups with regard to number of oocytes retrieved and clinical pregnancy rate (5.39 ± 2.08 vs. 5.20 ± 1.88 and 22.06% vs. 16.18%, respectively).The total gonadotropins dose and medications cost per cycle were significantly lower in extended letrozole group (44.87 ± 9.16 vs. 59.97 ± 14.91 ampoules and 616.52 ± 94.97 vs. 746.84 ± 149.21 US Dollars ($), respectively).The cost-effectiveness ratio was 2794 $ in extended letrozole group and 4616 $ in short letrozole group.

CONCLUSION: Extended letrozole regimen/HPuFSH-GnRHant protocol was more cost-effective than short letrozole regimen/HPuFSH-GnRHant protocol in poor responders undergoing IVF-ET.

Fouda, U., H. Elshaer, M. Taymour, F. Darweesh, and A. Wali, Extended doxycycline treatment versus aspiration of hydrosalpingeal fluid at the time of oocyte retrieval in the management of patients with ultrasound visible hydrosalpinx undergoing IVF-ET, , vol. 33: OXFORD UNIV PRESS GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND, pp. 260 - 260, 2018. Abstract
n/a
Fouda, M. E., and A. G. Radwan, "On the fractional-order memristor model", Journal of Fractional Calculus and Applications, vol. 4, no. 1, pp. 1–7, 2013. Abstract
n/a
Fouda, M. E., A. Allagui, A. S. Elwakil, A. Eltawil, and F. Kurdahi, "Supercapacitor discharge under constant resistance, constant current and constant power loads", Journal of Power Sources, vol. 435: Elsevier, pp. 226829, 2019. Abstract
n/a
Fouda, M. E., and A. G. Radwan, "Memristor-based voltage-controlled relaxation oscillators", International Journal of Circuit Theory and Applications, vol. 42, no. 10, pp. 1092–1102, 2014. Abstract
n/a
Fouda, R., H. Ammar, E. Sobhy, and A. M. Amin, "Unusual cause of pericardial effusion.", BMJ case reports, vol. 2012, 2012. Abstract

A 65-year-old Egyptian lady suffering from non-alcoholic liver cirrhosis was referred to our unit for evaluation of a massive pericardial effusion. Few weeks before presentation, she suffered from progressive abdominal distention and dyspnoea. She denied fever, rigors or other cardiorespiratory symptoms. Examination revealed shrunken liver, spleenomegaly and ascites. Chest was clear to auscultation and heart sounds were distant. Chest radiograph showed cardiomegaly and clear lung fields. Abdominal ultrasound confirmed the results of abdominal examination. Transthoracic echocardiogram (TTE) revealed a massive pericardial effusion (PEF) and rheumatic mitral stenosis. Chest tomography showed PEF and clear lung fields. One litre of exudate was removed via TTE-guided needle pericardiocentesis. A pericardio-peritoneal shunt was suspected, which was confirmed via a radioisotopic study. This case is among very few cases that reported PEF in a cirrhotic ascetic patient secondary to a radio-isotopically confirmed pericardio-peritoneal shunt in the literature.

Fouda, Abdel-Maksoud, G., Saad, F., Gobouri, A. A., M. Saleh, and El-Sadany, M.A., "The efficacy of silver nitrate (AgNO3) as a coating agent for protecting papers against high deteriorating microbes", Catalysts, vol. 11, issue 310, pp. 1-18, 2021.
Fouda, A., "Ultrasonic therapy as an adjunct treatment of temporomandibular joint dysfunction", The Journal of Oral and Maxillofacial Surgery , vol. 117, issue 5, pp. , 232-237, 2014.
Fouda, M. E., A. G. Radwan, and K. N. Salama, "Effect of boundary on controlled memristor-based oscillator", Engineering and Technology (ICET), 2012 International Conference on: IEEE, pp. 1–5, 2012. Abstract
n/a
Fouda, A. S., K. H. Attia, A. M. Abouelezz, M. A. El-Ghafour, and M. H. Aboulfotouh, "Anchorage control using miniscrews in comparison to Essix appliance in treatment of postpubertal patients with Class II malocclusion using Carrière Motion Appliance.", The Angle Orthodontist, 2021. Abstract
n/a
Fouda, M. E., A. S. Elwakil, A. Allagui, H. Rezk, and A. M. Nassef, "Communication?Convolution-Based Estimation of Supercapacitor Parameters under Periodic Voltage Excitations", Journal of The Electrochemical Society, vol. 166, no. 10: The Electrochemical Society, pp. A2267–A2269, 2019. Abstract
n/a
Fouda, R., H. Ammar, R. Edward, W. M. Alnabawy, and I. M. Fouda, "Tuberculous pericarditis associated with hoarseness of voice due to left recurrent laryngeal nerve paralysis.", BMJ case reports, vol. 2011, 2011. Abstract

A 16-years-old Egyptian girl presented with massive pericardial effusion, fever, weight loss and hoarseness of voice. Laryngoscopy showed left vocal cord paralysis. Chest CT revealed pericardial effusion, amalgamated mediastinal lymph nodes and clear lung fields. Pericardial fluid analysis revealed a lymphocytic exudate with high adenosine deaminase enzyme level, negative stains and cultures for bacteria and fungi. Despite a negative nucleic acid test for tuberculosis; antituberculous and corticosteroids therapies resulted in resolution of pericardial effusion after 3 weeks but hoarseness of voice persisted. Few cases of vocal cord paralysis with tuberculous mediastinal lymphadenopathy were reported in English literature.

Fouda M.S., Hendawey M.H., Hegazi G.A., Sharada H.M., El-Arabi Nagwa I., A. M.E., and S. E. R. and S, "Nanoparticles induce genetic, biochemical, and ultrastructure variations in Salvadora persica callus", Journal of Genetic Engineering and Biotechnology , vol. 19, issue 27, 2021.
Foudah, A. I., A. Alam, G. A. Soliman, M. A. Salkini, E. I. O. Ahmed, and H. S. Yusufoglu, "Pharmacognostical, Antioxidant and Antimicrobial studies of aerial part of Pulicaria crispa (Family: Asteraceae)", Bull. Env. Pharmacol. Life Sci, vol. 4, pp. 19–27, 2015. Abstract

The study was designed to investigate the active phytochemicals present in the methanolic extract (ME) of Pulicaria crispa (P. crispa). The antimicrobial and antioxidant activities were also explored. These investigations were carried with an aim to use this plant in future. The morphological, microscopical and physicochemical investigation was carried out before the investigation of phytochemicals for authentication purpose. The antimicrobial activity was tested against Gram-positive, Gram-negative bacteria, Aspergillus niger and Candida albicans. Ampicillin was used as a standard for comparing the zone of inhibition. The in vitro 2,2-Diphenyl-1-picrylhydrazyl (DPPH) and Ferric reducing ability (FRAP) models were used for the investigation of antioxidant activity. The results of the authenticated plant, phytochemical examination was shown the presence of biological active compounds. Marked antimicrobial and antioxidant activities were observed which may be due to the presence of tannins, phenols and flavonoids in the ME. The outcome of the present finding was suggested that it may be a good source of active antibacterial and antioxidant phytochemicals.

FOULADI, N. A. S. H. T. A. A. A., D. C. Wathes, and W. F. Marei, "EMBRYOLOGY: DIVERSE EFFECTS OF POLYUNSATURATED FATTY ACIDS ON OOCYTE MATURATION AND DEVELOPMENT IN VITRO", INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY, vol. 5, issue 1, pp. 31-32, 2011. Abstract
n/a
FOULADI, N. A. S. H. T. A. A. A., D. C. Wathes, and W. F. Marei, "EMBRYOLOGY: DIVERSE EFFECTS OF POLYUNSATURATED FATTY ACIDS ON OOCYTE MATURATION AND DEVELOPMENT IN VITRO", INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY, vol. 5, no. 1, pp. 31–32, 2011. Abstract
n/a
Fouladi-Nashta, A. A., F. Ghafari, and W. F. Marei, "Role of hyaluronic acid in maturation and further early embryo development of bovine oocytes", REPRODUCTION IN DOMESTIC ANIMALS, vol. 47: WILEY-BLACKWELL 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, pp. 454-454, 2012. Abstract
n/a
Fouladi-Nashta, A. A., W. Marei, and D. C. Wathes, "Diverse effects of polyunsaturated fatty acids on oocyte maturation and development in vitro", REPRODUCTION IN DOMESTIC ANIMALS, vol. 44: WILEY-BLACKWELL PUBLISHING, INC COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA, pp. 71–71, 2009. Abstract
n/a
Fouladi-Nashta, A. A., W. F. Marei, and F. Ghafari, "Small Size Hyluronan Promotes Bovine Oocyte Maturation and Embryo Development In Vitro.", BIOLOGY OF REPRODUCTION: SOC STUDY REPRODUCTION 1603 MONROE ST, MADISON, WI 53711-2021 USA, pp. 105-105, 2010. Abstract
n/a
Fouladi-Nashta, A., W. F. Marei, D. Schust, J. Sugimoto, T. Oda, Y. Jinno, Y. Hayashi, E. Mizutani, T. Kitaori, and K. Katano, "Session 67: Scientific challenges in early pregnancy achievement", Human Reproduction, vol. 28, issue suppl 1: ESHRE, pp. i106-i108, 2013. Abstract
n/a
Tourism